Determination of ivermectin in plasma and whole blood using LC-MS/MS
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Wattanakul T. et al, (2024), Nature Communications, 15
Determination of ivermectin in plasma and whole blood using LC-MS/MS
Kaewkhao N. et al, (2024), Wellcome Open Research, 9, 231 - 231
Simultaneous and enantiospecific quantification of primaquine and carboxyprimaquine in human plasma using liquid chromatography-tandem mass spectrometry
Hanpithakpong W. et al, (2022), Malaria Journal, 21
A Mitochondria-Penetrating Peptide Exerts Potent Anti-Plasmodium Activity and Localizes at Parasites' Mitochondria.
Somsri S. et al, (2021), Antibiotics (Basel), 10
Determinants of Primaquine and Carboxyprimaquine Exposures in Children and Adults with Plasmodium vivax Malaria
Chu CS. et al, (2021), Antimicrobial Agents and Chemotherapy, 65
The utility of an AMR dictionary as an educational tool to improve public understanding of antimicrobial resistance
Prapharsavat R. et al, (2021), Wellcome Open Research, 6, 113 - 113
A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa.
Klubthawee N. et al, (2020), Scientific reports, 10
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
Chotsiri P. et al, (2019), Nature Communications, 10
Enantiospecific pharmacokinetics and drug–drug interactions of primaquine and blood-stage antimalarial drugs
Chairat K. et al, (2018), Journal of Antimicrobial Chemotherapy, 73, 3102 - 3113
Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
Gilder ME. et al, (2018), Clinical Infectious Diseases, 67, 1000 - 1007
Structural and biological features of a novel plant defensin from Brugmansia x candida.
Kaewklom S. et al, (2018), PloS one, 13
Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia
Lohy Das J. et al, (2017), The AAPS Journal, 19, 1842 - 1854
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Awab GR. et al, (2016), Malaria Journal, 15
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
Chairat K. et al, (2016), British Journal of Clinical Pharmacology, 81, 1103 - 1112
Screening of phytochemicals and in vitro evaluation of antibacterial and antioxidant activities of leaves, pods and bark extracts of Acacia nilotica (L.) Del.
Sadiq MB. et al, (2015), Industrial Crops and Products, 77, 873 - 882
Lumefantrine and Desbutyl-Lumefantrine Population Pharmacokinetic-Pharmacodynamic Relationships in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria on the Thailand-Myanmar Border
Kloprogge F. et al, (2015), Antimicrobial Agents and Chemotherapy, 59, 6375 - 6384
Artemether‐lumefantrine co‐administration with antiretrovirals: population pharmacokinetics and dosing implications
Hoglund RM. et al, (2015), British Journal of Clinical Pharmacology, 79, 636 - 649
Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
Hanboonkunupakarn B. et al, (2014), Antimicrobial Agents and Chemotherapy, 58, 7340 - 7346